View Financial HealthZoono Group 배당 및 자사주 매입배당 기준 점검 0/6Zoono Group 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률-8.4%자사주 매입 수익률총 주주 수익률-8.4%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Oct 20Zoono Group Limited, Annual General Meeting, Nov 20, 2025Zoono Group Limited, Annual General Meeting, Nov 20, 2025. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000 Australia공고 • Aug 28Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,428,730 Price\Range: AUD 0.035 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 28,349,219 Price\Range: AUD 0.035 Transaction Features: Rights Offering공고 • Jun 21Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,776,259 Price\Range: AUD 0.035 Transaction Features: Rights OfferingBoard Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Oct 11Zoono Group Limited, Annual General Meeting, Nov 13, 2024Zoono Group Limited, Annual General Meeting, Nov 13, 2024. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000, AustraliaReported Earnings • Aug 22Full year 2024 earnings released: NZ$0.041 loss per share (vs NZ$0.002 loss in FY 2023)Full year 2024 results: NZ$0.041 loss per share (further deteriorated from NZ$0.002 loss in FY 2023). Revenue: NZ$1.05m (down 69% from FY 2023). Net loss: NZ$9.09m (loss widened NZ$8.74m from FY 2023).New Risk • May 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 99% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 32% per year over the past 5 years. Shareholders have been substantially diluted in the past year (99% increase in shares outstanding). Market cap is less than US$10m (AU$9.69m market cap, or US$6.46m). Minor Risk Revenue is less than US$5m (NZ$2.1m revenue, or US$1.3m).공고 • May 18Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,574,320 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct ListingReported Earnings • Feb 25First half 2024 earnings released: NZ$0.031 loss per share (vs NZ$0.008 profit in 1H 2023)First half 2024 results: NZ$0.031 loss per share (down from NZ$0.008 profit in 1H 2023). Revenue: NZ$650.4k (down 65% from 1H 2023). Net loss: NZ$5.93m (down NZ$7.30m from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.공고 • Feb 14Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,000,000 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct ListingBoard Change • Jan 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공고 • Dec 13+ 1 more updateZoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 66,786,854 Price\Range: AUD 0.027 Transaction Features: Rights Offering공고 • Oct 06Zoono Group Limited, Annual General Meeting, Nov 27, 2023Zoono Group Limited, Annual General Meeting, Nov 27, 2023, at 11:01 AUS Eastern Standard Time.Board Change • Oct 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 26Full year 2023 earnings released: NZ$0.002 loss per share (vs NZ$0.069 loss in FY 2022)Full year 2023 results: NZ$0.002 loss per share (improved from NZ$0.069 loss in FY 2022). Revenue: NZ$3.34m (down 63% from FY 2022). Net loss: NZ$350.4k (loss narrowed 97% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.New Risk • Aug 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 8.4% per year over the past 5 years. Market cap is less than US$10m (AU$8.55m market cap, or US$5.49m). Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (NZ$4.8m revenue, or US$2.8m).Reported Earnings • Feb 24First half 2023 earnings released: EPS: NZ$0.008 (vs NZ$0.012 loss in 1H 2022)First half 2023 results: EPS: NZ$0.008 (up from NZ$0.012 loss in 1H 2022). Revenue: NZ$1.85m (down 70% from 1H 2022). Net income: NZ$1.37m (up NZ$3.36m from 1H 2022). Profit margin: 74% (up from net loss in 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 20 percentage points per year, which is a significant difference in performance.Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 26Full year 2022 earnings released: NZ$6.82 loss per share (vs NZ$0.029 profit in FY 2021)Full year 2022 results: NZ$6.82 loss per share (down from NZ$0.029 profit in FY 2021). Revenue: NZ$9.02m (down 67% from FY 2021). Net loss: NZ$11.4m (down 341% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 208 percentage points per year, which is a significant difference in performance.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Buying Opportunity • Jan 25Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be NZ$0.52, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 92% per annum over the last 3 years. Earnings per share has grown by 91% per annum over the last 3 years.Reported Earnings • Aug 28Full year 2021 earnings released: EPS NZ$0.029 (vs NZ$0.10 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: NZ$27.1m (down 29% from FY 2020). Net income: NZ$4.73m (down 72% from FY 2020). Profit margin: 17% (down from 44% in FY 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 91% per year whereas the company’s share price has increased by 88% per year.Recent Insider Transactions • Jun 11CEO, MD & Director recently sold AU$4.9m worth of stockOn the 3rd of June, Paul Hyslop sold around 7m shares on-market at roughly AU$0.70 per share. This was the largest sale by an insider in the last 3 months. This was Paul's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improved over the past weekAfter last week's 20% share price gain to NZ$1.04, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 32x in the Chemicals industry in Australia. Total returns to shareholders of 604% over the past three years.Reported Earnings • Mar 02First half 2021 earnings released: EPS NZ$0.012 (vs NZ$0.004 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: NZ$14.4m (up NZ$12.7m from 1H 2020). Net income: NZ$1.91m (up NZ$2.63m from 1H 2020). Profit margin: 13% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 11New 90-day low: AU$0.93The company is down 34% from its price of AU$1.42 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NZ$1.05, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.1x. This compares to an average P/E of 36x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 268%.Is New 90 Day High Low • Jan 18New 90-day low: AU$1.27The company is down 17% from its price of AU$1.53 on 21 October 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.Is New 90 Day High Low • Dec 12New 90-day low: AU$1.32The company is down 39% from its price of AU$2.15 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 1.0% over the same period.Is New 90 Day High Low • Nov 24New 90-day low: AU$1.33The company is down 43% from its price of AU$2.33 on 26 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 2.0% over the same period.Valuation Update With 7 Day Price Move • Nov 03Market bids up stock over the past weekAfter last week's 21% share price gain to NZ$1.61, the stock is trading at a trailing P/E ratio of 16.5x, up from the previous P/E ratio of 13.7x. This compares to an average P/E of 18x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 283%.Is New 90 Day High Low • Oct 28New 90-day low: AU$1.33The company is down 41% from its price of AU$2.27 on 30 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period.Valuation Update With 7 Day Price Move • Oct 16Market pulls back on stock over the past weekAfter last week's 15% share price decline to NZ$1.55, the stock is trading at a trailing P/E ratio of 15.1x, down from the previous P/E ratio of 17.9x. This compares to an average P/E of 19x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 231%.Is New 90 Day High Low • Sep 30New 90-day low: AU$1.80The company is down 42% from its price of AU$3.10 on 02 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 ZNO 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: ZNO 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Zoono Group 배당 수익률 vs 시장ZNO의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ZNO)0%시장 하위 25% (AU)2.6%시장 상위 25% (AU)6.6%업계 평균 (Chemicals)2.1%분석가 예측 (ZNO) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 ZNO 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 ZNO 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: ZNO Australian 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: ZNO 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YAU 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/31 16:28종가2026/07/31 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Zoono Group Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Board Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 3 highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Oct 20Zoono Group Limited, Annual General Meeting, Nov 20, 2025Zoono Group Limited, Annual General Meeting, Nov 20, 2025. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000 Australia
공고 • Aug 28Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.777229 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 22,428,730 Price\Range: AUD 0.035 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 28,349,219 Price\Range: AUD 0.035 Transaction Features: Rights Offering
공고 • Jun 21Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.777169 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 50,776,259 Price\Range: AUD 0.035 Transaction Features: Rights Offering
Board Change • Dec 24Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Oct 11Zoono Group Limited, Annual General Meeting, Nov 13, 2024Zoono Group Limited, Annual General Meeting, Nov 13, 2024. Location: hall chadwick, level 40, 2 park street, sydney nsw 2000, Australia
Reported Earnings • Aug 22Full year 2024 earnings released: NZ$0.041 loss per share (vs NZ$0.002 loss in FY 2023)Full year 2024 results: NZ$0.041 loss per share (further deteriorated from NZ$0.002 loss in FY 2023). Revenue: NZ$1.05m (down 69% from FY 2023). Net loss: NZ$9.09m (loss widened NZ$8.74m from FY 2023).
New Risk • May 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 99% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (35% average weekly change). Earnings have declined by 32% per year over the past 5 years. Shareholders have been substantially diluted in the past year (99% increase in shares outstanding). Market cap is less than US$10m (AU$9.69m market cap, or US$6.46m). Minor Risk Revenue is less than US$5m (NZ$2.1m revenue, or US$1.3m).
공고 • May 18Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.366507 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,574,320 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct Listing
Reported Earnings • Feb 25First half 2024 earnings released: NZ$0.031 loss per share (vs NZ$0.008 profit in 1H 2023)First half 2024 results: NZ$0.031 loss per share (down from NZ$0.008 profit in 1H 2023). Revenue: NZ$650.4k (down 65% from 1H 2023). Net loss: NZ$5.93m (down NZ$7.30m from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.
공고 • Feb 14Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million.Zoono Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.054 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,000,000 Price\Range: AUD 0.027 Transaction Features: Subsequent Direct Listing
Board Change • Jan 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공고 • Dec 13+ 1 more updateZoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million.Zoono Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1.803245 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 66,786,854 Price\Range: AUD 0.027 Transaction Features: Rights Offering
공고 • Oct 06Zoono Group Limited, Annual General Meeting, Nov 27, 2023Zoono Group Limited, Annual General Meeting, Nov 27, 2023, at 11:01 AUS Eastern Standard Time.
Board Change • Oct 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 26Full year 2023 earnings released: NZ$0.002 loss per share (vs NZ$0.069 loss in FY 2022)Full year 2023 results: NZ$0.002 loss per share (improved from NZ$0.069 loss in FY 2022). Revenue: NZ$3.34m (down 63% from FY 2022). Net loss: NZ$350.4k (loss narrowed 97% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance.
New Risk • Aug 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 8.4% per year over the past 5 years. Market cap is less than US$10m (AU$8.55m market cap, or US$5.49m). Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Revenue is less than US$5m (NZ$4.8m revenue, or US$2.8m).
Reported Earnings • Feb 24First half 2023 earnings released: EPS: NZ$0.008 (vs NZ$0.012 loss in 1H 2022)First half 2023 results: EPS: NZ$0.008 (up from NZ$0.012 loss in 1H 2022). Revenue: NZ$1.85m (down 70% from 1H 2022). Net income: NZ$1.37m (up NZ$3.36m from 1H 2022). Profit margin: 74% (up from net loss in 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 20 percentage points per year, which is a significant difference in performance.
Board Change • Nov 17Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 26Full year 2022 earnings released: NZ$6.82 loss per share (vs NZ$0.029 profit in FY 2021)Full year 2022 results: NZ$6.82 loss per share (down from NZ$0.029 profit in FY 2021). Revenue: NZ$9.02m (down 67% from FY 2021). Net loss: NZ$11.4m (down 341% from profit in FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 208 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. Non-Executive Independent Director Don Clarke was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Jan 25Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be NZ$0.52, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 92% per annum over the last 3 years. Earnings per share has grown by 91% per annum over the last 3 years.
Reported Earnings • Aug 28Full year 2021 earnings released: EPS NZ$0.029 (vs NZ$0.10 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: NZ$27.1m (down 29% from FY 2020). Net income: NZ$4.73m (down 72% from FY 2020). Profit margin: 17% (down from 44% in FY 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 91% per year whereas the company’s share price has increased by 88% per year.
Recent Insider Transactions • Jun 11CEO, MD & Director recently sold AU$4.9m worth of stockOn the 3rd of June, Paul Hyslop sold around 7m shares on-market at roughly AU$0.70 per share. This was the largest sale by an insider in the last 3 months. This was Paul's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment improved over the past weekAfter last week's 20% share price gain to NZ$1.04, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 32x in the Chemicals industry in Australia. Total returns to shareholders of 604% over the past three years.
Reported Earnings • Mar 02First half 2021 earnings released: EPS NZ$0.012 (vs NZ$0.004 loss in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: NZ$14.4m (up NZ$12.7m from 1H 2020). Net income: NZ$1.91m (up NZ$2.63m from 1H 2020). Profit margin: 13% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 119% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 11New 90-day low: AU$0.93The company is down 34% from its price of AU$1.42 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NZ$1.05, the stock is trading at a trailing P/E ratio of 10.9x, down from the previous P/E ratio of 13.1x. This compares to an average P/E of 36x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 268%.
Is New 90 Day High Low • Jan 18New 90-day low: AU$1.27The company is down 17% from its price of AU$1.53 on 21 October 2020. The Australian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.
Is New 90 Day High Low • Dec 12New 90-day low: AU$1.32The company is down 39% from its price of AU$2.15 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 1.0% over the same period.
Is New 90 Day High Low • Nov 24New 90-day low: AU$1.33The company is down 43% from its price of AU$2.33 on 26 August 2020. The Australian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 2.0% over the same period.
Valuation Update With 7 Day Price Move • Nov 03Market bids up stock over the past weekAfter last week's 21% share price gain to NZ$1.61, the stock is trading at a trailing P/E ratio of 16.5x, up from the previous P/E ratio of 13.7x. This compares to an average P/E of 18x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 283%.
Is New 90 Day High Low • Oct 28New 90-day low: AU$1.33The company is down 41% from its price of AU$2.27 on 30 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period.
Valuation Update With 7 Day Price Move • Oct 16Market pulls back on stock over the past weekAfter last week's 15% share price decline to NZ$1.55, the stock is trading at a trailing P/E ratio of 15.1x, down from the previous P/E ratio of 17.9x. This compares to an average P/E of 19x in the Chemicals industry in Australia. Total returns to shareholders over the past three years are 231%.
Is New 90 Day High Low • Sep 30New 90-day low: AU$1.80The company is down 42% from its price of AU$3.10 on 02 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.